Patent · US Active

Method of profiling gene expression in a subject having alzheimer's disease

US8257922B2 · kind B2 · utility

40Cited by
4References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 9, 2010
Grant dateSep 4, 2012
Priority date
Expiry dateApr 9, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/143333
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is directed to detection and measurement of gene transcripts in blood. Specifically provided is a RT-PCR analysis performed on a drop of blood for detecting, diagnosing and monitoring diseases using tissue-specific primers. The present invention also describes methods by which delineation of the sequence and/or quantitation of the expression levels of disease-associated genes allows for an immediate and accurate diagnostic/prognostic test for disease or to assess the effect of a particular treatment regimen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.